{
  "html_url": "https://licitia.com.mx/adjudicacion/aa-12-nbd-012nbd001-i-236-2023",
  "canonical": "https://licitia.com.mx/adjudicacion/aa-12-nbd-012nbd001-i-236-2023",
  "id": "e5bed006fd674ba4ae16439950d67059",
  "procedure_number": "AA-12-NBD-012NBD001-I-236-2023",
  "file_number": "E-2023-00048939",
  "title": "ADQUISICION CONSOLIDADA DE MEDICAMENTOS DE PATENTE (23 CLAVES)",
  "description": {
    "short": "No existen bienes alternativos o sustitutos, Único Oferente, Derechos exclusivos (patentes, licencias, derechos de autor u otros derechos exclusivos), o por obras de arte.",
    "detailed": "ADQUISICION CONSOLIDADA DE MEDICAMENTOS DE PATENTE (23 CLAVES) PARA LOS EJERCICIOS  2023-2024"
  },
  "lifecycle": {
    "section": "concluido",
    "source_status": "ADJUDICADO",
    "moved_at": null
  },
  "buyer": {
    "agency": "HGM",
    "acronym": "HGM",
    "branch": "12 - SALUD",
    "buying_unit": "DIRECCION DE ADMINISTRACION Y FINANZAS",
    "requesting_unit": "unidad requiriente data",
    "requesting_group": "DIRECCION DE ADMINISTRACION Y FINANZAS",
    "entity": "HOSPITAL GENERAL DE MEXICO \"DR. EDUARDO LICEAGA\"",
    "slug": "hgm",
    "unit_slug": "direccion-de-administracion-y-finanzas-012nbd001"
  },
  "classification": {
    "procedure_type": "ADJUDICACIÓN DIRECTA",
    "contracting_type": "ADQUISICIONES",
    "publication_type": null,
    "character": "INTERNACIONAL ABIERTO",
    "fiscal_year": 2023,
    "law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
    "legal_basis_id": "22",
    "exception_basis": "Art. 41 fr. I",
    "internal_control_number": "CINSABI-178-2023",
    "supply_source_number": null
  },
  "schedule": {
    "published_at": "2023-06-14T19:40:48.000Z",
    "clarification_meeting_at": null,
    "clarification_questions_deadline_at": null,
    "clarification_responses_deadline_at": null,
    "bid_opening_at": null,
    "award_at": null,
    "estimated_contract_at": "2023-01-01T06:00:00.000Z",
    "site_visit_at": null,
    "estimated_work_start_at": null
  },
  "estimated_value": {
    "minimum": null,
    "maximum": null,
    "currency": "MXN",
    "updated_at": null
  },
  "lots": [
    {
      "number": "1",
      "name": "PARTIDA SOLA",
      "description": "PARTIDA SOLA",
      "requirement_group_id": "1",
      "items": [
        {
          "number": "1",
          "cucop_code": "25301-2628",
          "specific_item_code": "25301",
          "cucop_description": "010.000.5646.00 FLUTICASONA SUSPENSION EN AEROSOL NASAL 27.5 µ ENVASE CON 120 DISPAROS",
          "description": "FLUTICASONA. SUSPENSIÓN EN AEROSOL NASAL. CADA DISPARO PROPORCIONA: FUROATO DE FLUTICASONA 27.5 ¿G. ENVASE CON 120 DISPAROS.",
          "requested_quantity": "58",
          "minimum_quantity": "58",
          "maximum_quantity": "144",
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        },
        {
          "number": "2",
          "cucop_code": "25301-2628",
          "specific_item_code": "25301",
          "cucop_description": "010.000.5646.00 FLUTICASONA SUSPENSION EN AEROSOL NASAL 27.5 µ ENVASE CON 120 DISPAROS",
          "description": "FLUTICASONA. SUSPENSIÓN EN AEROSOL NASAL. CADA DISPARO PROPORCIONA: FUROATO DE FLUTICASONA 27.5 ¿G. ENVASE CON 120 DISPAROS.",
          "requested_quantity": "880",
          "minimum_quantity": "880",
          "maximum_quantity": "2200",
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        }
      ]
    }
  ],
  "awards": [
    {
      "id": "C-2023-00055812",
      "internal_reference": "CINSABI-178-2023",
      "title": "ADQUISICION CONSOLIDADA DE MEDICAMENTOS DE PATENTE (23 CLAVES)",
      "status": "PUBLICADO",
      "contractor": {
        "name": "GLAXOSMITHKLINE MEXICO SA DE CV",
        "normalized_name": "GLAXOSMITHKLINE MEXICO",
        "rfc_type": null,
        "slug": "glaxosmithkline-mexico"
      },
      "contract_period": {
        "published_at": "2023-06-14T19:40:48.000Z",
        "starts_at": "2023-01-01T06:00:00.000Z",
        "ends_at": "2024-12-31T06:00:00.000Z"
      },
      "value": {
        "subtotal": "95629.1",
        "tax": "0",
        "total": "95629.1",
        "maximum_subtotal": "238970.8",
        "maximum_total": "238970.8",
        "currency": "MXN"
      },
      "open_contract_type": null,
      "quantity": null,
      "exercised_quantity": null,
      "participants": [],
      "line_items": [
        {
          "number": "0",
          "cucop_code": "25301-2628",
          "description": "FLUTICASONA. SUSPENSIÓN EN AEROSOL NASAL. CADA DISPARO PROPORCIONA: FUROATO DE FLUTICASONA 27.5 ¿G. ENVASE CON 120 DISPAROS.",
          "unit": "PIEZA",
          "requested_quantity": "58",
          "awarded_quantity": null,
          "unit_price": "101.95",
          "subtotal": "5913.1",
          "tax": null,
          "other_taxes": null,
          "total": "5913.1"
        },
        {
          "number": "0",
          "cucop_code": "25301-2628",
          "description": "FLUTICASONA. SUSPENSIÓN EN AEROSOL NASAL. CADA DISPARO PROPORCIONA: FUROATO DE FLUTICASONA 27.5 ¿G. ENVASE CON 120 DISPAROS.",
          "unit": "PIEZA",
          "requested_quantity": "880",
          "awarded_quantity": null,
          "unit_price": "101.95",
          "subtotal": "89716",
          "tax": null,
          "other_taxes": null,
          "total": "89716"
        }
      ]
    }
  ],
  "documents": [
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "JUSTIFICACIÓN DE EXCEPCIÓN",
      "filename": "JustificaciÃ³n CAAS DEF.pdf",
      "availability": "available",
      "size_bytes": "10661335",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-09T03:03:49.904Z",
      "updated_at": "2025-12-09T03:03:49.906Z"
    },
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "ANEXO TÉCNICO",
      "filename": "FOCON 4 anexo tecnico.pdf",
      "availability": "available",
      "size_bytes": "66060012",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-09T03:04:21.638Z",
      "updated_at": "2025-12-09T03:04:21.639Z"
    },
    {
      "id": null,
      "annex_number": 5,
      "document_type": null,
      "description": "OFICIO DE ADJUDICACIÓN",
      "filename": "Notificacion Glaxosmithkline.pdf",
      "availability": "available",
      "size_bytes": "952091",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-09T03:04:23.337Z",
      "updated_at": "2025-12-09T03:04:23.338Z"
    }
  ],
  "alternates": [],
  "similar": [
    {
      "numero_procedimiento": "aa-50-gyr-050gyr005-t-272-2023",
      "nombre_procedimiento": "ADQUISICION DE MEDICAMENTO",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.05842280736105321
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr004-t-248-2023",
      "nombre_procedimiento": "ADQUISICIÓN DE CLAVES DE MEDICINAS EJERCICIO 2023",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.059542059898376465
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr024-i-204-2023",
      "nombre_procedimiento": "MEDICAMENTOS REQ. 173",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.06094691338976921
    },
    {
      "numero_procedimiento": "aa-12-ndf-012ndf999-i-840-2023",
      "nombre_procedimiento": "CONSOLIDADO/INSABI/INRLGII/6/2023-2024 GLAXOSMITHKLINE MEXICO, SA DE CV",
      "dependencia": "INR",
      "siglas": "INR",
      "score": 0.06123363241747759
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr024-i-157-2024",
      "nombre_procedimiento": "MEDICAMENTOS REQ. 112",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.06659489870071411
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr011-i-84-2023",
      "nombre_procedimiento": "AD-064-2023 MEDICAMENTO",
      "dependencia": "INSTITUTO MEXICANO DEL SEGURO SOCIAL",
      "siglas": "IMSS",
      "score": 0.07784903049468994
    }
  ]
}